15 Biggest Mid-Day Gainers For Wednesday

  • DelMar Pharmaceuticals Inc DMPI shares climbed 66.2 percent to $1.88 after announcing issuance of new patent for VAL-08.
  • Alnylam Pharmaceuticals, Inc. ALNY surged 37.1 percent to $102.90 following positive APOLLO 3 results.
  • Diffusion Pharmaceuticals Inc DFFN shares jumped 19.9 percent to $2.10.
  • Gemphire Therapeutics Inc GEMP shares climbed 12.1 percent to $10.73 after the company reported plans to advance gemcabene into Phase 3 development.
  • Arbutus Biopharma Corp ABUS shares rose 10.8 percent to $6.15.
  • Aluminum Corp. of China Limited (ADR) ACH shares climbed 9 percent to $23.26 after gaining 1.33 percent on Tuesday.
  • Shoe Carnival, Inc. SCVL gained 8.9 percent to $20.83. Susquehanna upgraded Shoe Carnival from Neutral to Positive.
  • Cesca Therapeutics Inc KOOL shares rose 8.2 percent to $3.58. Cesca Therapeutics reported FY17 loss of $3.27 per share on revenue of $14.5 million.
  • CymaBay Therapeutics Inc CBAY surged 8 percent to $7.55. Cantor Fitzgerald initiated coverage on CymaBay Therapeutics with an Overweight rating.
  • Imax Corp (USA) IMAX shares rose 6.4 percent to $23.40 after falling 0.68 percent on Tuesday.
  • Supercom Ltd SPCB shares climbed 6.4 percent to $2.83.
  • Trio-Tech International TRT gained 5.9 percent to $4.85. Trio-Tech reported Q4 earnings of $0.09 per share on sales of $10.638 million.
  • Hibbett Sports, Inc. HIBB rose 5 percent to $13.80. Susquehanna upgraded Hibbett from Neutral to Positive.
  • Copart, Inc. CPRT surged 3.6 percent to $33.72 as the company posted stronger-than-expected results for its fourth quarter.
  • Karyopharm Therapeutics Inc KPTI shares rose 3.1 percent to $10.84 after the company reported that SEAL study's primary endpoint of progression-free survival showed superiority over placebo.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼
Posted In: NewsIntraday UpdateMarketsAnalyst RatingsMoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!